ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/11/2026

1. ORCL
2. SPY
3. SPCX
4. CHWY
5. NAVN
6. USO
7. HUMA
8. cASY
9. CME
10. OXM

Go back to ZIRCON Phase III Kidney Cancer Imaging Study Completes Target Enrolment
TRANS-LUX CORPORATION (NASDAQ: TLX) Delayed: 9.39 -0.05 (0.53%)
Previous Close $9.44    52 Week High $2.18 
Open $9.42    52 Week Low $0.30 
Day High $9.54    P/E N/A 
Day Low $9.34    EPS $-3.32 
Volume 64,719